Verax specializes in non-THC cannabidiol research, rare disease product development, laboratory proficiency testing, and CBD product development.
Verax blends our scientific, medical, manufacturing, technology, education, sourcing, and development skills into products and services applicable to many segments of the cannabidiol market. Our service units include, but are not limited to the following specialties:
Orphan Drug Product Research and Product Development:
Verax has developed a compelling vision using non-THC cannabidiol in rare diseases (e.g., less than 200,000 US cases per year). See our Orphan Drug page for more details.
Laboratory Proficiency and Product Testing Certification Services:
There are over 160 independent CBD laboratories in the US. Through no fault of their own, there is no laboratory proficiency certification model that is used by all the labs. Verax has created a model for proficiency and challenge testing that is economical and will align all CBD lab results. We believe the public deserves this level of transparency. Once Verax proficiency testing has been established, we will work with CBD and supplement providers to verify that the contents of their products correctly reflect their labeling. See our Lab page for more details.
Verax Product Development Services:
Using our clinical experience Verax has developed a special line of high-potency CBD products that will be sold only in pharmacies and clinician offices. We believe that higher-potency CBD products should be only considered through consultation with a clinician. The product line is called Clinician Limited and will soon be sold across the country. See the Clinician Limited page for more details.
Verax Product Sourcing and Design Services:
Designing and sourcing custom product formulations containing non-THC cannabinoid constituents for various industries including food and cosmetics.